CDC panel meets to discuss Johnson & Johnson vaccine blood clot issue

75756A5E-120A-4932-810C-2FD980DB785E

A Centers for Disease Control and Prevention advisory committee is meeting Wednesday to review clinical data regarding the six women known to have developed blood clots and low platelet counts after getting the Johnson & Johnson COVID-19 vaccine.

Stanford University professor of pediatrics Dr. Grace Lee is on that Advisory Committee on Immunization Practices and is listed as one of those who will be presenting data at the meeting.

Any recommendations from Wednesday's meeting will be sent to the director of the CDC, who decides whether to make them official policy. The U.S. Food and Drug Administration will also review the committee's recommendations.

"We are trying to figure out right now is whether these unfortunate cases of clots are in fact related to the vaccine itself," U.S. Surgeon General Dr. Vivek Murthy said. "The fact that this is being paused tells you about how seriously we’re taking adverse events, and how safety is really a critical priority when it comes to moving this larger vaccine campaign forward."

The meeting agenda indicates a vote will happen Wednesday afternoon.

In the meantime, use of the Johnson & Johnson vaccine has been put on "pause" across most of the country.

The meeting is being streamed on the CDC website.

Featured Image Photo Credit: ocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech is reflected in the glass of a fume hood as she prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020 in Aurora, Colorado.